Morgan Stanley Downgrades WuXi PharmaTech (WX) to Equalweight
Tweet
Share
E-mailGet Alerts WX Hot Sheet
Price: $25.30 --0%
Rating Summary:
7 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 7 | New: 3
Rating Summary:
7 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 7 | New: 3
Join SI Premium – FREE
Morgan Stanley downgraded WuXi PharmaTech (NYSE: WX) from Overweight to Equalweight.
For an analyst ratings summary and ratings history on WuXi PharmaTech click here. For more ratings news on WuXi PharmaTech click here.
Shares of WuXi PharmaTech closed at $43.57 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Berenberg Downgrades Lanxess AG (LXS:GR) (LNXSF) to Sell
- JPMorgan Downgrades Legal & General Group PLC (LGEN:LN) (LGGNF) to Underweight
- Kepler Cheuvreux Downgrades Carl Zeiss Meditec AG (AFXG:GR) (CZMWY) to Reduce
Create E-mail Alert Related Categories
DowngradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
